Most bought healthcare stocks in Q2 2022
See which Healthcare stocks institutional investors increased the most in Q2 2022, measured as net growth in reported share positions from Q1 2022 into Q2 2022. Notable additions at the top of this list include ELANCO ANIMAL HEALTH INC (ELAN), ALVOTECH SA (ALVO), TELADOC HEALTH INC (TDOC), ALVOTECH SA (ALVOW). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| ELAN | ELANCO ANIMAL HEALTH INC | 19,993,594 | $174.25M | 0 | 1 | 3 | 1 | 5 |
| ALVO | ALVOTECH SA | 6,338,660 | $52.04M | 1 | 0 | 0 | 0 | 1 |
| TDOC | TELADOC HEALTH INC | 4,890,565 | -$602.44M | 0 | 3 | 2 | 0 | 5 |
| ALVOW | ALVOTECH SA | 4,666,667 | $3.92M | 1 | 0 | 0 | 0 | 1 |
| AGL | AGILON HEALTH INC | 4,197,772 | $81.11M | 1 | 1 | 0 | 0 | 2 |
| BLCO | BAUSCH + LOMB CORP | 3,500,000 | $53.34M | 1 | 0 | 0 | 0 | 1 |
| OPK | OPKO HEALTH INC | 3,389,058 | $8.02M | 1 | 1 | 0 | 1 | 3 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 3,109,818 | $242.48M | 1 | 6 | 4 | 0 | 12 |
| GDRX | GOODRX HOLDINGS INC-CLASS A | 2,863,336 | $11.53M | 1 | 2 | 0 | 0 | 3 |
| EMBC | EMBECTA CORP | 2,760,038 | $69.88M | 5 | 0 | 0 | 0 | 5 |
| ZOM | ZOMEDICA CORP | 2,507,500 | $550.00K | 1 | 0 | 0 | 0 | 2 |
| INCY | INCYTE CORP | 2,402,710 | $99.43M | 0 | 2 | 4 | 0 | 6 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 2,292,300 | $23.15M | 0 | 1 | 0 | 0 | 1 |
| HCA | HCA HEALTHCARE INC | 2,030,644 | $62.78M | 1 | 4 | 2 | 1 | 7 |
| BLUE | BLUEBIRD BIO INC | 1,870,000 | $7.07M | 0 | 1 | 0 | 0 | 1 |
| ACHC | ACADIA HEALTHCARE CO INC | 1,843,930 | $129.38M | 1 | 2 | 0 | 1 | 3 |
| PEPG | PEPGEN INC | 1,793,923 | $17.81M | 1 | 0 | 0 | 0 | 1 |
| BSX | BOSTON SCIENTIFIC CORP | 1,766,184 | -$142.22M | 0 | 2 | 2 | 2 | 5 |
| FMS | FRESENIUS MEDICAL CARE-ADR | 1,734,910 | -$78.04M | 1 | 1 | 1 | 0 | 4 |
| VTRS | VIATRIS INC | 1,696,113 | $16.27M | 0 | 2 | 2 | 0 | 6 |
| MCK | MCKESSON CORP | 1,667,945 | $661.19M | 2 | 3 | 3 | 0 | 9 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 1,552,374 | $256.10M | 0 | 4 | 5 | 0 | 9 |
| OSUR | ORASURE TECHNOLOGIES INC | 1,496,116 | $341.00K | 0 | 1 | 0 | 0 | 1 |
| CAH | CARDINAL HEALTH INC | 1,450,164 | $57.60M | 2 | 2 | 3 | 0 | 8 |
| ABCL | ABCELLERA BIOLOGICS INC | 1,418,700 | $18.06M | 0 | 1 | 0 | 0 | 2 |
| ACCD | ACCOLADE INC | 1,413,869 | -$49.53M | 1 | 2 | 0 | 0 | 3 |
| CDNA | CAREDX INC | 1,211,792 | -$19.79M | 0 | 3 | 0 | 0 | 3 |
| AQST | AQUESTIVE THERAPEUTICS INC | 1,192,100 | $695.00K | 0 | 1 | 0 | 0 | 1 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES | 1,094,252 | -$214.46M | 0 | 2 | 0 | 0 | 3 |
| AMGN | AMGEN INC | 1,059,470 | $259.68M | 0 | 5 | 6 | 0 | 12 |
| DXCM | DEXCOM INC | 1,051,905 | $45.55M | 0 | 4 | 0 | 0 | 4 |
| STXS | STEREOTAXIS INC | 1,048,531 | -$2.66M | 0 | 3 | 0 | 0 | 3 |
| SY | SO-YOUNG INTERNATIONAL-ADR | 1,030,300 | $464.00K | 0 | 1 | 0 | 0 | 1 |
| TWST | TWIST BIOSCIENCE CORP | 1,003,466 | -$46.60M | 0 | 1 | 0 | 0 | 2 |
| TGTX | TG THERAPEUTICS INC | 986,828 | $3.02M | 0 | 2 | 0 | 0 | 3 |
| CVS | CVS HEALTH CORP | 972,563 | -$50.80M | 1 | 4 | 11 | 0 | 16 |
| ME | 23ANDME HOLDING CO -CLASS A | 970,200 | -$411.00K | 0 | 1 | 1 | 1 | 2 |
| MRVI | MARAVAI LIFESCIENCES HLDGS-A | 959,754 | $20.98M | 0 | 1 | 1 | 0 | 2 |
| EXEL | EXELIXIS INC | 921,659 | -$12.04M | 0 | 1 | 0 | 0 | 2 |
| AZN | ASTRAZENECA PLC-SPONS ADR | 917,090 | $59.02M | 0 | 2 | 4 | 0 | 7 |
| BEAM | BEAM THERAPEUTICS INC | 871,215 | -$149.76M | 1 | 1 | 0 | 0 | 2 |
| HOLX | HOLOGIC INC | 868,822 | $4.79M | 0 | 2 | 4 | 0 | 7 |
| MGNX | MACROGENICS INC | 845,211 | -$939.00K | 0 | 1 | 0 | 0 | 1 |
| PSNL | PERSONALIS INC | 835,436 | -$19.40M | 0 | 2 | 0 | 0 | 2 |
| SPRO | SPERO THERAPEUTICS INC | 829,917 | -$253.00K | 0 | 1 | 0 | 0 | 1 |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | 816,630 | $23.85M | 1 | 1 | 0 | 0 | 2 |
| TMO | THERMO FISHER SCIENTIFIC INC | 786,281 | $220.31M | 0 | 7 | 6 | 1 | 17 |
| PBH | PRESTIGE CONSUMER HEALTHCARE | 781,053 | $48.57M | 1 | 1 | 2 | 0 | 4 |
| ALHC | ALIGNMENT HEALTHCARE INC | 771,523 | $9.89M | 0 | 2 | 0 | 0 | 2 |
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 740,118 | $9.38M | 0 | 1 | 2 | 0 | 4 |
Frequently asked questions about Most bought healthcare stocks in Q2 2022
What are the most bought Healthcare stocks in Q2 2022?
The most bought healthcare stocks in Q2 2022 are those with the largest increase in reported share counts across institutional investors compared to Q1 2022, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q2 2022?
Among filers in this sector, net additions were largest in companies such as ELANCO ANIMAL HEALTH INC (ELAN), ALVOTECH SA (ALVO), TELADOC HEALTH INC (TDOC), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q1 2022).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.